Cleared Traditional

K231877 - NavaClick Injection System

K231877 is an FDA 510(k) clearance for NavaClick Injection System, manufactured by Lineage Biomedical, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 157-day FDA review.

K231877 · Lineage Biomedical, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2023
Decision
157d
Days
Class 2
Risk

K231877 is an FDA 510(k) clearance for the NavaClick Injection System. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Lineage Biomedical, Inc. (Stuart, US). The FDA issued a Cleared decision on November 30, 2023 after a review of 157 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Lineage Biomedical, Inc. devices

FDA 510(k) Submission Details - K231877

510(k) Number K231877 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2023
Decision Date November 30, 2023
Days to Decision 157 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 129d · This submission: 157d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 329
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K231877.
Medline Luer Lock Syringes
K230235 · Medline Industries, LP · Feb 2024
SMB Luer lock disposable syringe
K231558 · Smb Corporation of India · Jan 2024
Insulin Syringe
K230061 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Nov 2023
Revital Cady
K231519 · Revital Healthcare (Epz) Limited · Nov 2023
EpiZact
K233056 · Guidestar Medical Devices · Nov 2023
Disposable Sterile Syringe
K221777 · Weihai Shengjie Medical Technology Co., Ltd. · Oct 2023